301371.SZ
Harbin Fuerjia Technology Co., Ltd.
SZSE · C 制造业 · CN
CNY 20.07
−0.50%Sep 22, 2026, 06:17 UTC
Fuerjia's first injectable Class III medical device, 'Fuerjia Huaji Dongnengsu', is expected to launch in October 2026, marking the company's entry into the injectable medical aesthetics market.
Source:Aug 19, 2026, 07:46 UTC
Fuerjia announced its first-half 2026 results with revenue of 1.156 billion yuan, up 33.95% year-on-year, and net profit attributable to shareholders of 256 million yuan, up 11.46%.
Source:Aug 12, 2026, 07:58 UTC
Fuerjia's stock fell 3.07% to close at 25.61 yuan on August 12, 2026, remaining below its IPO price.
Source:Aug 10, 2026, 07:53 UTC
CITIC Securities conducted an on-site inspection of Fuerjia's 2025 annual continuous supervision work, and the inspection showed that the company complied with relevant requirements in corporate governance, internal control, related-party transactions, and use of raised funds, with no issues found during the on-site inspection.
Source: